Triatec

• Antihypertensive Agents
• Angiotensin-converting Enzyme Inhibitors
• ATC:C09AA05

• Acovil
• Altace
• Carasel
• Cardace
• Delix
• Hytren
• Lostapres
• Pramace
• Quark
• Ramace
• Ramipril [Usan:Ban:Inn]
• Ramiprilum [Latin]
• Triatec
• Tritace
• Unipril
• Vesdil

No information avaliable

C₂₃H₃₂N₂O₅

http://www.rxlist.com/cgi/generic/ramipril.htm

Triatec MSDS

EH Gold et al. US Pat. 4.587.258 (1967).

416.511 g/mol

109 ^oC

3,5 mg / L

Solid

3.149

Capsula

Per i diuretici e digitale nello scompenso cardiaco congestizio come terapia aggiuntiva e per l'uso in profilassi in post infarto miocardico.

Ramipril è un enzima di conversione dell'angiotensina (ACE) simile a benazepril, fosinopril, e quinapril. Un profarmaco inattivo, ramipril a ramiprilato viene convertito nel fegato ed è usata per trattare ipertensione e insufficienza cardiaca, di ridurre la proteinuria e la malattia renale in pazienti affetti da nefropatie, e per prevenire l'ictus, infarto miocardico e morte cardiaca nei pazienti ad alto rischio.

Il grado di assorbimento è almeno del 50-60% e non è significativamente influenzato dalla presenza di cibo nel tratto GI, anche se il tasso di assorbimento si riduce.

Le più probabili manifestazioni cliniche sarebbero sintomi attribuibili ad ipotensione. LD50 = 10933 mg / kg (per via orale nei topi).

Pregnancy: Female patients of childbearing age should be told about the consequences of second- and third-trimester exposure to ACE inhibitors, and they should also be told that these consequences do not appear to have resulted from intrauterine ACE-inhibitor exposure that has been limited to the first trimester. These patients should be asked to report pregnancies to their physicians as soon as possible.

Angioedema: Angioedema, including laryngeal edema, can occur with treatment with ACE inhibitors, especially following the first dose. Patients should be so advised and told to report immediately any signs or symptoms suggesting angioedema (swelling of face, eyes, lips, or tongue, or difficulty in breathing) and to take no more drug until they have consulted with the prescribing physician.

Symptomatic Hypotension: Patients should be cautioned that lightheadedness can occur, especially during the first days of therapy, and it should be reported. Patients should be told that if syncope occurs, ramipril should be discontinued until the physician has been consulted.

All patients should be cautioned that inadequate fluid intake or excessive perspiration, diarrhea, or vomiting can lead to an excessive fall in blood pressure, with the same consequences of lightheadedness and possible syncope.

Hyperkalemia: Patients should be told not to use salt substitutes containing potassium without consulting their physician.

Neutropenia: Patients should be told to promptly report any indication of infection (e.g., sore throat, fever), which could be a sign of neutropenia.

Gli esseri umani e altri mammiferi